Cardlytics, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
CDLX
Cardlytics, INCChristopher Chi-Kit Cheng, Chief Legal & Privacy Officer of Cardlytics, Inc., received 50,000 shares of common stock on August 3, 2026.
NASDAQ
CDLX
Cardlytics, INCCardlytics CEO Amit Gupta reported transactions involving the sale of company stock following a 1-for-10 reverse stock split.
NASDAQ
CDLX
Cardlytics, INCNicholas Hollmeyer, Chief Legal & Privacy Officer at Cardlytics, Inc., reported transactions involving the acquisition and disposition of common stock and restricted stock units.
NASDAQ
CDLX
Cardlytics, INCCardlytics, Inc. director Srishti A. Gupta acquired 11,000 shares of common stock through the vesting of restricted stock units.
NASDAQ
CDLX
Cardlytics, INCCardlytics, Inc. Director Scott A. Hill reported the acquisition of 11,000 shares of common stock through the vesting of restricted stock units.
NASDAQ
CDLX
Cardlytics, INCDirector Andre Fernandez reported the acquisition of 11,000 restricted stock units of Cardlytics, Inc. (CDLX) on May 20, 2026.
NASDAQ
CDLX
Cardlytics, INCDirector Liane Hornsey reported the acquisition of 11,000 restricted stock units of Cardlytics, Inc. on May 20, 2026.
NASDAQ
CDLX
Cardlytics, INCJohn L. Klinck Jr., a Director at Cardlytics, Inc., acquired 11,000 shares of common stock through the vesting of restricted stock units.
NASDAQ
CDLX
Cardlytics, INCForm 4: Cardlytics CFO Buys Shares
Cardlytics, Inc. Chief Financial Officer David Thomas Evans acquired a significant number of company shares through multiple transactions in mid-May 2026.
NASDAQ
CDLX
Cardlytics, INCCardlytics, Inc. CEO Amit Gupta sold 69,833 shares of common stock to cover tax obligations from vested RSUs.
NASDAQ
CDLX
Cardlytics, INCCardlytics CEO Amit Gupta reported transactions involving the sale of company stock to cover tax obligations from vested Restricted Stock Units (RSUs).
NASDAQ
CDLX
Cardlytics, INCCardlytics Chief Legal Officer Nicholas Hollmeyer sold shares to cover tax obligations upon RSU vesting.
NASDAQ
CDLX
Cardlytics, INCCardlytics, Inc. Chief Financial Officer David Thomas Evans was granted 1,000,000 Restricted Stock Units under a Rule 10b5-1(c) plan.
NASDAQ
CDLX
Cardlytics, INCCardlytics' Chief Legal & Privacy Officer, Nicholas Lynton, sold 6,253 shares of common stock to cover tax withholdings from vested restricted stock units.
NASDAQ
CDLX
Cardlytics, INCCardlytics CEO Amit Gupta sold 5,807 shares of common stock at a weighted average price of $1.17 to cover tax withholding obligations from RSU vesting.
NASDAQ
CDLX
Cardlytics, INCCardlytics' Chief Financial Officer, Alexis DeSieno, sold shares to cover tax obligations following the vesting of restricted stock units.
NASDAQ
CDLX
Cardlytics, INCCardlytics Director Srishti A. Gupta acquired 6,148 shares of common stock through the vesting and conversion of restricted stock units on October 30, 2025.
NASDAQ
CDLX
Cardlytics, INCCardlytics Chief Legal & Privacy Officer, Nicholas Lynton, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax withholding obligations.
NASDAQ
CDLX
Cardlytics, INCCardlytics CEO Amit Gupta exercised restricted stock units and subsequently sold a portion of the common stock to satisfy tax withholding obligations.
NASDAQ
CDLX
Cardlytics, INCCardlytics CFO Alexis DeSieno sold 8,493 shares of common stock to cover tax withholdings following the vesting of 14,350 restricted stock units.
NASDAQ
CDLX
Cardlytics, INCCardlytics Director and 10% owner Clifford Sosin sold 400,000 shares of common stock over two days in August 2025.
NASDAQ
CDLX
Cardlytics, INCCardlytics CEO Amit Gupta sold 136,945 shares of common stock to cover tax withholding obligations following the vesting of 250,000 restricted stock units.
NASDAQ
CDLX
Cardlytics, INCCardlytics CFO Alexis DeSieno sold 26,048 shares of common stock at a weighted average price of $1.217 to cover tax obligations following the vesting of 43,750 restricted stock units.
NASDAQ
CDLX
Cardlytics, INCCardlytics CEO Amit Gupta reported the vesting of 14,349 restricted stock units and the subsequent sale of 6,725 shares to cover tax withholding obligations.
NASDAQ
CDLX
Cardlytics, INCCardlytics Chief Financial Officer Alexis DeSieno reported the acquisition of 14,349 common shares through restricted stock unit vesting and the subsequent sale of 7,324 shares at a weighted average price of $1.7826 to cover tax obligations.
NASDAQ
CDLX
Cardlytics, INCCardlytics' Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, reported the vesting of restricted stock units and a subsequent sale of shares solely to cover tax obligations.
NASDAQ
CDLX
Cardlytics, INCForm 4: Cardlytics Director Clifford Sosin Reports Internal Distribution of Shares and Convertible Notes
Clifford Sosin, a Director and 10% owner of Cardlytics, Inc., reported pro rata distributions of common stock and convertible senior notes to partners of investment vehicles he manages, with no consideration exchanged.
NASDAQ
CDLX
Cardlytics, INCCardlytics, Inc. Chief Financial Officer Alexis DeSieno was granted 55,000 contingent equity awards, comprising Restricted Stock Units and Performance Stock Units, aligning her interests with shareholder value.
NASDAQ
CDLX
Cardlytics, INCCardlytics, Inc. (CDLX) has granted its Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, 25,000 Restricted Stock Units (RSUs) and 9,375 Performance Stock Units (PSUs) as part of his compensation.
NASDAQ
CDLX
Cardlytics, INCCardlytics, Inc. has granted its Chief Executive Officer and Director, Amit Gupta, a total of 1.3 million contingent equity units, comprising Restricted Stock Units and Performance Stock Units, as part of his compensation.